Carmen Somarriba, PA-C

Carmen Somarriba practices at Mobile Visiting Practitioners in Daytona Beach, Florida.

Carmen Somarriba's NPI, 1932602620, was assigned on March 9, 2018. Carmen Somarriba holds Florida license PA9111038.

Carmen Somarriba's primary practice is Mobile Visiting Practitioners, at 140 S Beach St, Daytona Beach, FL 32114 in Volusia County. The practice phone is (888) 506-8836.

Carmen Somarriba's primary practice is Mobile Visiting Practitioners in Daytona Beach, Florida. The medical group on file is Mobile Visiting Practitioners. Dmand AI also links Carmen Somarriba to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Carmen Somarriba practices. Vendor and product names are available with a free account.

Physician assistant is Carmen Somarriba's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Carmen Somarriba is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, itchy rashes, minor head injury and minor injury to a limb among the conditions Carmen Somarriba treats.

CMS data shows 321 Medicare services from Carmen Somarriba across 4 procedure codes in 2024, for 207 Medicare patients. Medicare paid $28,398 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 207 Medicare patients who saw Carmen Somarriba in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have depression, and 75% have high blood pressure. 88% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Carmen Somarriba's median patient age at 75, with 58% women.

In 2024, Carmen Somarriba wrote 74 Medicare Part D claims for 40 patients. 92% of them were for generic drugs. CMS names the drug for 25 of them, across 1 drug with 11 or more claims each, at $644 in total drug cost.

Carmen Somarriba accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Carmen Somarriba from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $120.